These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 17559481

  • 1. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
    Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV.
    Pain Pract; 2007 Jun; 7(2):123-9. PubMed ID: 17559481
    [Abstract] [Full Text] [Related]

  • 2. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N, Sittl R, Likar R.
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [Abstract] [Full Text] [Related]

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Aug; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 4. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 5. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R.
    Expert Rev Neurother; 2005 May; 5(3):315-23. PubMed ID: 15938664
    [Abstract] [Full Text] [Related]

  • 6. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R, Kayser H, Sittl R.
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [Abstract] [Full Text] [Related]

  • 7. Treatment of ischemic pain in patients suffering from peripheral vasculopathy with transdermal buprenorphine plus epidural morphine with ropivacaine vs. epidural morphine with ropivacaine.
    Aurilio C, Pace MC, Passavanti MB, Paladini A, Maisto M, Iannotti M, Pota V, D'amora E, Sansone P, Barbarisi M.
    Pain Pract; 2009 Jun; 9(2):105-14. PubMed ID: 19019049
    [Abstract] [Full Text] [Related]

  • 8. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
    Tschirner M, Ritzdorf I, Brünjes R.
    MMW Fortschr Med; 2008 Sep 18; 150 Suppl 3():142-8. PubMed ID: 19025217
    [Abstract] [Full Text] [Related]

  • 9. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R.
    Palliat Med; 2006 Sep 18; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [Abstract] [Full Text] [Related]

  • 10. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
    Pergolizzi JV, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S, Lybaert W, Beniak J, Orońska A, Slama O, Euromed Communications meeting.
    Curr Med Res Opin; 2009 Jun 18; 25(6):1517-28. PubMed ID: 19435402
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.
    Clin Ther; 2005 Apr 18; 27(4):451-62. PubMed ID: 15922818
    [Abstract] [Full Text] [Related]

  • 12. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S.
    J Pain Symptom Manage; 2009 Apr 18; 37(4):632-41. PubMed ID: 19345298
    [Abstract] [Full Text] [Related]

  • 13. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R, Likar R, Nautrup BP.
    Clin Ther; 2005 Feb 18; 27(2):225-37. PubMed ID: 15811486
    [Abstract] [Full Text] [Related]

  • 14. Transdermal buprenorphine combined with spinal morphine and naropine for pain relief in chronic peripheral vasculopathy.
    Aurilio B, Pace MC, Passavanti MB.
    Minerva Anestesiol; 2005 Feb 18; 71(7-8):445-9. PubMed ID: 16012418
    [Abstract] [Full Text] [Related]

  • 15. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S, Villari P, Ferrera P, Porzio G, Aielli F, Verna L, Casuccio A.
    J Pain Symptom Manage; 2006 Aug 18; 32(2):175-9. PubMed ID: 16877185
    [Abstract] [Full Text] [Related]

  • 16. Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.
    Brema F, Pastorino G, Martini MC, Gottlieb A, Luzzani M, Libretti A, Saccà L, Cigolari S.
    Int J Clin Pharmacol Res; 1996 Aug 18; 16(4-5):109-16. PubMed ID: 9172009
    [Abstract] [Full Text] [Related]

  • 17. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S, Sydoruk T, White I, Ekstein MP, Marouani N, Chazan S, Skornick Y, Weinbroum AA.
    Clin Ther; 2009 Mar 18; 31(3):527-41. PubMed ID: 19393843
    [Abstract] [Full Text] [Related]

  • 18. Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study.
    Mercadante S, Porzio G, Ferrera P, Aielli F, Verna L, Tirelli W, Villari P, Casuccio A.
    Clin Ther; 2009 Oct 18; 31(10):2134-8. PubMed ID: 19922884
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK, Bijur PE, Baccelieri A, Gallagher EJ.
    Am J Geriatr Pharmacother; 2009 Feb 18; 7(1):1-10. PubMed ID: 19281935
    [Abstract] [Full Text] [Related]

  • 20. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J.
    Pain Physician; 2012 Jul 18; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.